Skip to main content

Advertisement

SpringerLink
Log in

Osteonecrosis of the femoral head and glaucoma caused by topical corticosteroid application

  • Case Report
  • Published:
Modern Rheumatology

Abstract

A 37-year-old man was diagnosed with bilateral osteonecrosis of the femoral head (ONFH) and glaucoma. He had no risk factors for either ONFH or glaucoma, except for 24 years’ continuous use of topical corticosteroid ointments for treating atopic dermatitis. We determined that the topical steroid had caused both the pathological conditions. It is necessary to recognize that continuous topical corticosteroid therapy may cause the same pathological conditions as those caused by the systemic administration of these agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Williams LC, Nesbitt LT Jr. Update on systemic glucocorticosteroids in dermatology. Dermatol Clin. 2001;19(1):63–77.

    Article  PubMed  CAS  Google Scholar 

  2. Sugano N, Atsumi T, Ohzono K, Kubo T, Hotokebuchi T, Takaoka K. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci. 2002;7(5):601–5.

    Article  PubMed  Google Scholar 

  3. Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am. 2006;88:1117–32.

    Article  PubMed  Google Scholar 

  4. Cunliffe WJ, Burton JL, Holti G, Wright V. Hazards of steroid therapy in hepatic failure. Br J Dermatol. 1975;93:183–5.

    Article  PubMed  CAS  Google Scholar 

  5. Tang SC, Chan KC, Chow SP. Osteonecrosis of femoral head after topical steroid therapy. J R Coll Surg Edinb. 1986;5(31):321–3.

    Google Scholar 

  6. Hogan DJ, Sibley JT, Lane PR. Avascular necrosis of the hips following long-term use of clobetasol propionate. J Am Acad Dermatol. 1986;41:515–7.

    Article  Google Scholar 

  7. McLean CJ, Lobo RF, Brazier DJ. Cataracts, glaucoma and femoral avascular necrosis caused by topical corticoid ointment. Lancet. 1995;345(8945):330

    Google Scholar 

  8. el Maghraoui A, Tabache F, Bezza A, Ghafir D, Ohayon V, Archane MI. Femoral head osteonecrosis after topical corticosteroid therapy. Clin Exp Rheumatol. 2001;19(2):233

    Google Scholar 

  9. Pénétrat SR, Tréchot P, Barbaud A, Gillet P, Schmutz JL. Bilateral femoral avascular necrosis in a man with psoriasis: responsibility of topical corticosteroids and role of cyclosporine. Dermatology. 2001;203(4):356–7.

    Article  Google Scholar 

  10. Kubo T, Kojima A, Yamazoe S, Ueshima K, Yamamoto T, Hirasawa Y. Osteonecrosis of the femoral head that developed after long-term topical steroid application. J Orthop Sci. 2001;6(1):92–4.

    Article  PubMed  CAS  Google Scholar 

  11. Hales RH. Glaucoma induced by careless use of steroids. J Pediatr Ophthalmol. 1973;10:206–7.

    Google Scholar 

  12. Katsushima H. Corticoid-induced glaucoma following treatment of the periorbital lesion. Nippon Ganka Gakkai Zasshi. 1995;99(2):238–43.

    PubMed  CAS  Google Scholar 

  13. Kakinuma N, Takeda N, Mizunoya S. Corticosteroid glaucoma in patients of atopic dermatitis. Rinsho Ganka. 2001;55(4):646–9.

    Google Scholar 

  14. Yano S. Choice of steroids and their usage (in Japanese). Tokyo: Nanko-do; 1990. p. 173–81.

  15. Sakaguchi M, Fukushima W, Hirota Y. Tanaka T, Yamamoto T, Jingushi S. et al. Risk factors associated with the development of idiopathic osteonecrosis of the femoral head: a nationwide multicenter case-control study (in Japanese). Research project of Ministry of Health, Labour and Welfare for intractable disease, Interdisciplinary research for standardization of prevention and treatment for idiopathic osteonecrosis of the femoral head. Annual report of 2008. 2009. p. 35–39.

  16. Coleman AL. Glaucoma. Lancet. 1999;354(9192):1803–10.

    Article  PubMed  CAS  Google Scholar 

  17. Karkoulias K, Charokopos N, Kaparianos A, Sampsonas F, Tsiamita M, Spiropoulos K. Aseptic femoral head necrosis in a patient receiving long term courses of inhaled and intranasal corticosteroids. Tuberk Toraks. 2007;55(2):182–5.

    PubMed  Google Scholar 

  18. Opatowsky I, Feldman RM, Gross R, Feldman ST. Intraocular pressure elevation associated with inhalation and nasal corticosteroids. Ophthalmology. 1995;102(2):177–9.

    PubMed  CAS  Google Scholar 

  19. van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, et al. Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice. Ann Rheum Dis. 2010;69(11):1913–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Hisashi Takeda for his excellent advice.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, 920-8641, Japan

    Tamon Kabata, Keito Shimanuki & Hiroyuki Tsuchiya

  2. Department of Pharmacy, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, 920-8641, Japan

    Kiichi Shimanuki

Authors
  1. Tamon Kabata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keito Shimanuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kiichi Shimanuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroyuki Tsuchiya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tamon Kabata.

About this article

Cite this article

Kabata, T., Shimanuki, K., Shimanuki, K. et al. Osteonecrosis of the femoral head and glaucoma caused by topical corticosteroid application. Mod Rheumatol 21, 706–709 (2011). https://doi.org/10.1007/s10165-011-0473-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-011-0473-0

Keywords

Search

Navigation